How population genetics shapes complex traits and disease risk
Population Genetics Methods for Understanding Complex Trait Evolution
Researchers are creating and applying genetic methods to show how population history and DNA differences influence complex traits and disease risk for people with genetic conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-11180335 on NIH RePORTER |
What this research studies
This project builds and improves computer methods to analyze very large genetic and health datasets from biobanks. The team uses population-genetics ideas to find genome regions shaped by evolution and spots where harmful variants concentrate. They validate these tools on human genomic datasets and release software so other researchers can use them. From my perspective, this helps explain why different groups may have different genetic risks for the same conditions.
Who could benefit from this research
Good fit: People whose DNA and health records are already in research biobanks or who are willing to donate genomic data and medical information would be most relevant to this work.
Not a fit: Individuals without any genomic data in research resources, or whose conditions are driven entirely by environmental factors, are unlikely to see direct benefits in the short term.
Why it matters
Potential benefit: Could improve understanding of how genetic risk varies across populations, leading to better risk prediction and more equitable research that informs future treatments.
How similar studies have performed: Related population-genetics methods and software have been widely used and cited, though translating those findings into direct patient care is still developing.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Szpiech, Zachary Alfano — Pennsylvania State University, the
- Study coordinator: Szpiech, Zachary Alfano
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.